TowardPi completed the C-round financing of nearly 300 million yuan. This round of financing was led by Shanghai Sun Rock Capital, followed by Tao Capital, Kunlun Capital and other institutions. Old shareholders Eyebright, Tsingstone Capital continued to increase their weight in this round.

At present, TowardPi Medical has 240 employees, of which the R&D team accounts for one third. There are two R&D centers in Beijing and Shanghai, with an annual R&D investment of nearly 100 million yuan. 40% of the R&D personnel have more than 10 years of senior industrial technology experience, and 30% of the R&D personnel graduated from the top 100 universities in the world.